Forth Therapeutics
ItalyEntry
2023
Hold
3yr
Status
Active
Who owns Forth Therapeutics?
Forth Therapeutics is currently owned by Sofinnova Partners through Sofinnova Biovelocita I (2022 vintage), since 2023. Across its history, Forth Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Biovelocita I · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Biovelocita I · 2022 · Life Sciences VC
Old College CapitalActive
2025 · present(1yr) · Old College Capital LP · 2011 · Evergreen
More from Sofinnova Biovelocita I
Other portfolio companies in the same fund.
More Sofinnova Partners portfolio companies
From the same investor, across funds.
France
US
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Forth Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Forth Therapeutics?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Forth Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue